The growing demand for autoimmune diseases and advancement in technology is fostering market growth. Market Size – USD 9.29 Billion in 2019, Market Growth - CAGR of 17.7%, Market Trends – Rise in cardiovascular incidences. The global Autologous Cell Therapy Product market is forecast to reach USD 35.64 Billion by 2027, according to a new report by Reports and Data....

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Manufacturing Market, 2021-2030.”  The report...

High target disease prevalence, product launches, and increasing strategic developments such as partnerships and agreements are driving the market for cell therapy. Market Size – USD 5.79 Billion in 2019, Market Growth - CAGR of 5.6%, Market Trends – Advancement in technology. The global Cell Therapy Market is forecast to reach USD 8.75 Billion by 2027, according to a new...

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.   Roots Analysis is pleased to...